November 5, 2025

Type 2 Diabetes in Remission — Understanding the New E11.A Code for FY 2026

The FY 2026 ICD-10-CM update, effective October 1, 2025, introduced a new diagnosis code — E11.A (Type 2 diabetes mellitus in remission). 


This addition reflects growing recognition that some patients can achieve long-term remission of Type 2 diabetes, often after significant lifestyle changes or metabolic interventions such as bariatric surgery.  For inpatient coders, this change allows for more precise data capture and accurate representation of a patient’s current clinical status. 


What’s New 

Prior to FY 2026, coders had limited options when providers documented phrases such as “Type 2 diabetes resolved” or “in remission.” These cases often led to inconsistent coding, since the only available choices were: 

 

  • E11.xx — Active diabetes, or 
  • No diabetes code at all 

 

The addition of E11.A closes that gap. It recognizes patients who no longer meet the clinical criteria for active diabetes but remain at increased risk for recurrence. Type 2 DM in remission has been defined as achieving an HbA1C level of less than 6.5% for at least three months after cessation of all glucose lowering medication. 


Documentation Requirements 

To code E11.A, provider documentation must clearly state that the patient’s diabetes is “in remission.” 


The term “controlled” or “well-controlled” is not enough — these still represent active disease. 


Terms such as “history of T2DM” and “resolved T2DM” might be documented, but are not synonymous with T2DM in remission. When it is unclear, a provider should be queried 


 

Here’s what coders should confirm in the health record: 

 

  • Provider statement: The provider must explicitly state “Type 2 diabetes mellitus in remission.” 
  • Treatment status: The patient should not be taking insulin or oral hypoglycemics. 
  • Lab results: Normal glucose or HbA1c levels may support the remission status, but cannot be coded on their own without provider confirmation. 
  • Duration of remission: While not required for coding, duration (e.g., “in remission for 2 years”) strengthens the clinical picture. 

 


Coding Example 

Documentation:  “Patient with prior history of Type 2 diabetes, now maintains normal blood glucose and A1c after bariatric surgery. No current medications. Type 2 diabetes in remission.” 


Code Assignment: 

 

  • E11.A — Type 2 diabetes mellitus in remission 

 

If the provider instead documents “controlled” or “diet-controlled diabetes,” continue to assign E11.9 — Type 2 diabetes mellitus without complications. 


Common Pitfalls 

 

  • Coding based on labs alone: Do not assign E11.A without a provider statement. 
  • Using ‘history of diabetes’ only: A “history of” note without mention of remission does not qualify for E11.A. 
  • Applying to Type 1 diabetes: The remission concept applies only to Type 2 diabetes at this time. 
  • Omitting secondary risk codes: Consider Z86.39 (Personal history of other endocrine disorders) if the provider documents long-term follow-up without current disease.

 


Why This Matters 

 

  • Accurate use of E11.A improves: Clinical communication: Providers and coders share a clear understanding of disease status. 
  • Population health data: Public health agencies can track remission rates more accurately. 
  • Risk adjustment and quality metrics: Prevents overcoding active disease, which can affect reporting, reimbursement, and care management metrics. 
  • This small but meaningful change encourages better alignment between coding and real-world outcomes — reflecting advances in diabetes treatment and remission recognition. 

 



References 

 

  • FY 2026 ICD-10-CM Official Guidelines for Coding and Reporting (Effective 10/1/2025) Section 1.C.4.A.1.b 
  • ICD-10-CM/PCS Coding Clinic, Fourth Qtr ICD-10 2025, Pages 6-7 

 

Jessica Lutz, MBA, RHIA, CCS, Senior Consultant, Audit at UASI

Jessica Lutz, MBA, RHIA, CCS 
AHIMA Micro-credential: Auditing: Inpatient Coding   

Senior Consultant, Audit at UASI


Jessica Lutz serves as a Senior Consultant in Auditing at UASI and is recognized for her ICD-10-CM/PCS expertise and inpatient coding background. She shares coding tips from an auditor’s perspective, highlighting common pitfalls and practical ways coders and CDI teams can improve accuracy and documentation quality.

MRI brain scans illustrating symptoms of PRES with title text overlay.
December 9, 2025
Learn the symptoms of PRES, key treatment considerations, ICD-10-CM code I67.83, and documentation tips for CDI and accurate DRG assignment.
Microscopic immune cells interacting in cellular environment, illustrating immune effector activity
By Katie Curry December 1, 2025
Understand ICANS documentation and ICD-10 coding with guidance on the ICANS grading system, ICE score, clinical indicators, and CAR T-cell neurotoxicity.
Fingerstick blood glucose test being performed, illustrating screening and monitoring practices for gestational diabetes.
By Katie Curry November 3, 2025
Gestational Diabetes
Clinician pointing to anatomical kidney model illustrating acute kidney injury.
By Katie Curry October 20, 2025
Learn how to identify, document, and code acute kidney injury (AKI), including diagnostic criteria, staging, ICD-10-CM guidance, and CDI query considerations.
Blurred hospital scene symbolizing CDI review of firearm injury intent reporting.
By Katie Curry September 30, 2025
Learn how firearm injury intent is documented and reported in ICD-10-CM, including intent categories, external cause codes, and documentation considerations.
Title image for the ventricular standstill clinical documentation and coding overview
By Katie Curry September 22, 2025
Learn how ventricular standstill is documented and coded, including clinical indicators, ICD-10-CM guidance, and common documentation considerations.
Title image for neurostorming (PSH) documentation and coding
By Katie Curry September 7, 2025
Learn how neurostorming, also known as paroxysmal sympathetic hyperactivity (PSH), is documented and coded using ICD-10-CM guidance.
Title photo of doctor for New ICD-10-CM code E11.A for type 2 diabetes mellitus in remission
By Katie Curry August 7, 2025
FY 2026 ICD-10-CM coding guidance for new code E11.A, Type 2 diabetes mellitus without complications in remission, including documentation and query considerations.
By Katie Curry July 9, 2025
Definition: Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurologic function in the earliest days of life in a term or late preterm infant, manifested by difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and often seizures. Clinical presentation: Low APGAR scores and/or weak/absent cry in the delivery room. Hyperalert, irritable, lethargic, obtunded. Decreased spontaneous movements, poor tone, blunted or absent primitive reflexes, seizure activity. Breathing and/or feeding difficulties. Documentation Tips: The CDS should review to identify the underlying etiology . (e.g., hypoxic-ischemic event, infection, metabolic disorder). Review clinical indicators that may indicate associated conditions , such as seizures, abnormal imaging, acidosis, or multi-organ dysfunction. Review the documentation for the timing of onset (e.g., at birth, delayed). Common clinical indicators include low APGAR scores, need for resuscitation, abnormal tone, or altered level of consciousness.  ICD-10-CM Coding: P91.811, Neonatal encephalopathy in diseases classified elsewhere P91.819, Neonatal encephalopathy, unspecified Use when the type or etiology of NE is not documented Query Example: To the Attending Neonatologist: Documentation in the medical record indicates the newborn infant delivered from mother with placental abruption demonstrates seizures, abnormal muscle tone, low APGAR scores, and required resuscitation at birth. Imaging showed evidence of cerebral edema. The diagnosis of “neonatal encephalopathy” was documented in the assessment. Query: Based on the clinical indicators, can you clarify the type and cause of the encephalopathy in this newborn? Please select the most appropriate option below or specify another diagnosis: Neonatal encephalopathy due to Hypoxic-ischemic encephalopathy (HIE) Neonatal encephalopathy due to other etiology (please specify) Other (please specify): __________
By Katie Curry May 12, 2025
Definition: Tumor lysis syndrome (TLS) is an oncologic emergency caused by massive tumor cell lysis and the release of large amounts of potassium, phosphate, and uric acid into the systemic circulation. Deposition of uric acid and/or calcium phosphate crystals in the renal tubules can result in acute kidney injury.
Show More